NCT00561769已完成不适用
Growth Hormone co-Treatment Within a GnRH Agonist Long Protocol in Patients With Poor Ovarian Response
Gulhane School of Medicine1 个研究点 分布在 1 个国家目标入组 61 人开始时间: 2005年1月最近更新:
适应症
干预措施
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 61
- 试验地点
- 1
- 主要终点
- mature oocyte number
研究概览
简要总结
Commencing of growth hormone in luteal phase when follicular cohort for the next cycle is being gathered may increase mature oocytes in poor responder
研究设计
- 研究类型
- Observational
- 观察模型
- Case Control
- 时间视角
- Prospective
入排标准
- 年龄范围
- 20 Years 至 40 Years（Adult）
- 性别
- Female
- 接受健康志愿者
- 否
入选标准
- •Poor responder
排除标准
- •FSH >20 IU
研究组 & 干预措施
A
poor responder
干预措施: Norditropin pen (Drug)
结局指标
主要结局
mature oocyte number
时间窗: 2 years
次要结局
- pregnancy rate(2 years)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Growth Hormone for Poor Responders in in Vitro Fertilization (IVF)Poor Ovarian ReserveInfertilityNCT01204840Ottawa Fertility Centre38
Unknown
2 期
Growth Hormone Co-treatment Within a GnRH Antagonist Protocol in Patients With Poor Ovarian ResponseInfertility, FemaleNCT03373149Riyadh Fertility and Reproductive Health center228
终止
4 期
Growth Hormone and GnRH Agonist in Adolescents With Acquired HypothyroidismHypothyroidismNCT00206375Baylor College of Medicine16
Unknown
1 期
Gonadotrophin Releasing Hormone Agonist Addition for Luteal Support in In-vitro Fertilization and Embryo Transfer CyclesLPS GnRHaNCT02908438Northwest Women's and Children's Hospital, Xi'an, Shaanxi400
已完成
4 期
Early Follicular Supplementation of Ganirelix in IVF 2004IVF TreatmentInfertilityNCT00461422The Baruch Padeh Medical Center, Poriya50